HomeNewsScreenerChartsMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ETON

Eton Pharmaceuticals Inc

Last Close
May 27  •  04:00PM ET
32.40
Dollar change
+1.11
Percentage change
3.55 %
Healthcare • Drug Manufacturers - Specialty & Generic • USA • Small • NASD
Peers: ANIP AMRX PRGO BHC ALKS INDV LNTH TEVA VTRS HRMY
 | Held by: IWM VTI IWO VXF VTWO IWC ITOT GSSC AVSC VTWG
Scroll to Statements
Index
RUT
P/E
-
EPS (ttm)
-0.07
Insider Own
4.97%
Shs Outstand
27.36M
Perf Week
-1.49%
Market Cap
887.52M
Forward P/E
17.07
EPS next Y
1.90
Insider Trans
-6.84%
Shs Float
26.03M
Perf Month
38.17%
Enterprise Value
899.12M
PEG
0.16
EPS next Q
0.15
Inst Own
65.17%
Short Float
6.28%
Perf Quarter
83.57%
Income
-1.48M
P/S
10.21
EPS this Y
129.34%
Inst Trans
4.53%
Short Ratio
3.95
Perf Half Y
96.84%
Sales
86.93M
P/B
28.95
EPS next Y
136.45%
ROA
-1.62%
Short Interest
1.63M
Perf YTD
91.60%
Book/sh
1.12
P/C
45.14
EPS next 5Y
105.03%
ROE
-5.36%
52W High
35.66 -9.14%
Perf Year
61.68%
Cash/sh
0.72
P/FCF
57.52
EPS past 3/5Y
21.89% 33.66%
ROIC
-2.95%
52W Low
13.09 147.61%
Perf 3Y
740.03%
Dividend Est.
-
EV/EBITDA
139.18
Sales past 3/5Y
55.53% 359.57%
Gross Margin
54.77%
Volatility
6.63% 6.62%
Perf 5Y
281.63%
Dividend TTM
-
EV/Sales
10.34
EPS Y/Y TTM
68.13%
Oper. Margin
2.65%
ATR (14)
1.85
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
0.88
Sales Y/Y TTM
79.89%
Profit Margin
-1.70%
RSI (14)
60.72
Recom
1.00
Dividend Gr. 3/5Y
- -
Current Ratio
1.21
EPS Q/Q
184.27%
SMA20
6.29%
Beta
0.87
Target Price
43.38
Payout
-
Debt/Eq
1.02
Sales Q/Q
40.41%
SMA50
21.70%
Rel Volume
1.07
Prev Close
31.29
Employees
44
LT Debt/Eq
0.63
Earnings
May 14 AMC
SMA200
65.07%
Avg Volume
413.28K
Price
32.40
IPO
Nov 13, 2018
Option/Short
Yes / Yes
EPS/Sales Surpr.
23.57% 8.76%
Trades
Volume
440,884
Change
3.55%
Date Action Analyst Rating Change Price Target Change
Jan-23-25Reiterated H.C. Wainwright Buy $17 → $33
Jan-10-25Initiated B. Riley Securities Buy $21
Jan-06-25Reiterated H.C. Wainwright Buy $15 → $17
Sep-04-24Resumed H.C. Wainwright Buy $9
May-06-24Initiated Craig Hallum Buy $8
Oct-14-21Resumed B. Riley Securities Buy $10
Jan-04-21Reiterated H.C. Wainwright Buy $20 → $15
Sep-20-19Initiated B. Riley FBR Buy $13.50
Jun-10-19Initiated H.C. Wainwright Buy $15
May-19-26 04:30PM
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO (miltefosine)
(GlobeNewswire)
May-15-26 08:30AM
Eton Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary
(Moby)
01:02AM
Eton Pharmaceuticals Inc (ETON) Q1 2026 Earnings Call Highlights: Record Sales and Strategic ...
(GuruFocus.com)
May-14-26 04:05PM
Eton Pharmaceuticals Reports First Quarter 2026 Financial Results
(GlobeNewswire)
May-12-26 04:30PM
Eton Pharmaceuticals to Participate in Upcoming Investor Conferences
(GlobeNewswire)
04:30PM Loading…
May-04-26 04:30PM
Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
(GlobeNewswire)
May-01-26 06:50AM
Eton Pharmaceuticals relaunches HEMANGEOL (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution
(GlobeNewswire) +19.82%
Apr-27-26 06:50AM
Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700
(GlobeNewswire)
Apr-16-26 06:50AM
Eton Pharmaceuticals Announces CFO Succession Plan
(GlobeNewswire) -9.42%
Mar-19-26 11:01PM
Eton Pharmaceuticals Inc (ETON) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ...
(GuruFocus.com) +9.20% +7.46%
08:18PM
Eton Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary
(Moby)
04:05PM
Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
(GlobeNewswire)
Mar-03-26 04:30PM
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026
(GlobeNewswire)
Mar-02-26 07:27AM
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL (propranolol hydrochloride) Oral Solution
(GlobeNewswire) +6.83%
Feb-25-26 01:47PM
Eton Pharmaceuticals Announces U.S. FDA Approval for DESMODA (desmopressin acetate) Oral Solution
(GlobeNewswire)
06:50AM Loading…
Feb-20-26 06:50AM
Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th
(GlobeNewswire)
Feb-02-26 06:50AM
Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate
(GlobeNewswire)
Dec-04-25 03:28PM
Implied Volatility Surging for Eton Pharmaceuticals Stock Options
(Zacks)
Nov-24-25 04:30PM
Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th
(GlobeNewswire)
Nov-12-25 04:30PM
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th
(GlobeNewswire)
Nov-06-25 05:35PM
Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates
(Zacks) -11.70%
04:05PM
Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results
(GlobeNewswire)
Nov-05-25 07:49AM
Eton Pharmaceuticals Inc (ETON) Q3 2025 Earnings Report Preview: What To Expect
(GuruFocus.com)
Oct-23-25 04:30PM
Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
(GlobeNewswire)
Sep-22-25 12:57PM
Implied Volatility Surging for Eton Pharmaceuticals Stock Options
(Zacks)
Aug-20-25 06:50AM
Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference
(GlobeNewswire)
Aug-07-25 06:10PM
Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Tops Revenue Estimates
(Zacks) +12.32%
04:05PM
Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results
(GlobeNewswire)
Jul-31-25 10:00AM
Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
(Zacks)
Jul-28-25 07:00AM
Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025
(GlobeNewswire)
10:05AM Loading…
Jul-11-25 10:05AM
Adrenal Crisis Market Analysis and Forecast Report 2025-2035 with Competitive Benchmarking of Eton Pharmaceuticals, Antares Pharma, and Pfizer
(GlobeNewswire) -6.88%
Jul-08-25 06:50AM
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)
(GlobeNewswire) +9.80%
Jun-27-25 06:50AM
Eton Pharmaceuticals Announces Addition to Russell 2000 and Russell 3000 Indexes
(GlobeNewswire)
Jun-02-25 12:00PM
Eton Pharmaceuticals (ETON) Upgraded to Buy: Here's Why
(Zacks)
08:50AM
Eton Pharmaceuticals (ETON) Is a Great Choice for 'Trend' Investors, Here's Why
(Zacks)
May-29-25 07:12AM
FDA approves Etons application for hydrocortisone oral solution
(Pharmaceutical Technology) -5.78%
May-28-25 11:49PM
Eton Pharmaceuticals, Inc. (ETON) Launches Game-Changer for Adrenal Insufficiency
(Insider Monkey)
05:28PM
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI (hydrocortisone) Oral Solution
(GlobeNewswire)
May-14-25 04:30PM
Eton Pharmaceuticals to Participate at Upcoming Investor Conferences
(GlobeNewswire) +15.07%
09:19AM
Q1 2025 Eton Pharmaceuticals Inc Earnings Call
(Thomson Reuters StreetEvents)
03:17AM
Eton Pharmaceuticals Inc (ETON) Q1 2025 Earnings Call Highlights: Revenue Soars 117% Amid ...
(GuruFocus.com)
May-13-25 05:15PM
Eton Pharmaceuticals, Inc. (ETON) Q1 Earnings Lag Estimates
(Zacks)
04:01PM
Eton Pharmaceuticals Reports First Quarter 2025 Financial Results
(GlobeNewswire)
May-12-25 09:32AM
Eton Pharmaceuticals Inc (ETON) Q1 2025 Earnings Report Preview: What To Expect
(GuruFocus.com)
May-08-25 05:45PM
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates
(Zacks)
May-07-25 10:00AM
Earnings Preview: Merus N.V. (MRUS) Q1 Earnings Expected to Decline
(Zacks)
May-01-25 04:30PM
Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025
(GlobeNewswire)
10:01AM
Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 Release
(Zacks)
Apr-28-25 06:50AM
Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)
(GlobeNewswire)
Apr-01-25 07:00AM
Eton Pharmaceuticals Out-Licenses International Rights to Increlex
(GlobeNewswire)
Mar-21-25 10:56PM
Eton Pharmaceuticals Inc (ETON) Q4 2024 Earnings Report Preview: What To Expect
(GuruFocus.com)
Mar-18-25 08:00AM
Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates
(Zacks)
06:50AM
Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results
(GlobeNewswire)
Mar-14-25 06:50AM
Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600
(GlobeNewswire) +6.71%
Mar-04-25 06:50AM
Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025
(GlobeNewswire)
Mar-03-25 06:50AM
Eton Pharmaceuticals Announces Commercial Launch of Galzin (zinc acetate) Capsules
(GlobeNewswire)
Feb-10-25 07:11AM
Eton secures US patent for diabetes insipidus treatment
(Pharmaceutical Technology)
Feb-07-25 06:50AM
Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600
(GlobeNewswire)
Feb-06-25 06:50AM
Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400
(GlobeNewswire)
Jan-25-25 09:15AM
Eton Pharmaceuticals price target raised to $23 from $18 at Craig-Hallum
(TipRanks)
Jan-24-25 04:17AM
Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength?
(Zacks)
Jan-15-25 01:46PM
Eton Pharmaceuticals, Inc. (ETON): Analysts Recommend This 52-Week High Stocks Now
(Insider Monkey) +6.56%
Jan-03-25 06:50AM
Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin
(GlobeNewswire) -9.15%
Dec-20-24 06:50AM
Eton Pharmaceuticals Closes Acquisition of Increlex (mecasermin injection)
(GlobeNewswire)
Dec-17-24 06:50AM
Eton Pharmaceuticals Announces Final Readout of PKU GOLIKE® Clinical Trial
(GlobeNewswire)
Dec-03-24 06:50AM
Eton Pharmaceuticals Appoints Ipek Erdogan-Trinkaus as Chief Commercial Officer
(GlobeNewswire) -5.14%
Nov-26-24 09:48AM
Eton acquires US rights to neonatal diabetes treatment from AMMTeK
(Pharmaceutical Technology)
06:55AM
Eton Pharmaceuticals acquires U.S. rights to Amglidia from AMMTeK
(TipRanks)
Nov-25-24 06:50AM
Eton Pharmaceuticals Announces Acquisition of U.S. Rights to Amglidia (Glyburide Oral Suspension)
(GlobeNewswire) +7.12%
Nov-13-24 07:09AM
Q3 2024 Eton Pharmaceuticals Inc Earnings Call
(Thomson Reuters StreetEvents) +15.59%
02:18AM
Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings Call Highlights: Record Sales and Strategic ...
(GuruFocus.com)
Nov-12-24 04:01PM
Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results
(GlobeNewswire) -5.56%
Nov-11-24 07:18AM
What To Expect From Eton Pharmaceuticals Inc (ETON) Q3 2024 Earnings
(GuruFocus.com) +10.59%
Nov-07-24 07:00AM
Eton Pharmaceuticals Awarded Second Patent for ET-400 (Hydrocortisone Oral Solution)
(GlobeNewswire)
Nov-06-24 04:30PM
Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
(GlobeNewswire)
Oct-29-24 09:30AM
Eton Pharmaceuticals price target raised to $15 from $10 at Craig-Hallum
(TipRanks)
Oct-28-24 11:01AM
Opaleye Management Inc. Reduces Stake in Eton Pharmaceuticals Inc.
(GuruFocus.com)
Oct-17-24 04:15PM
SWK Holdings Provides Portfolio Update
(ACCESSWIRE)
Oct-09-24 01:02AM
Opaleye Management Inc. Bolsters Portfolio with Strategic Acquisition of Eton Pharmaceuticals Shares
(GuruFocus.com)
Oct-03-24 06:30AM
Eton Pharmaceuticals, Inc to Acquire Increlex (mecasermin injection) from Ipsen
(GlobeNewswire) +16.33%
Sep-13-24 02:22AM
Opaleye Management Inc. Increases Stake in Eton Pharmaceuticals Inc.
(GuruFocus.com) +6.85%
Aug-22-24 04:30PM
Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
(GlobeNewswire) +6.82%
Aug-08-24 09:59PM
ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
(InvestorPlace)
04:01PM
Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results
(GlobeNewswire)
Jul-30-24 05:30PM
Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
(GlobeNewswire)
Jul-17-24 04:15PM
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
(ACCESSWIRE)
Jul-15-24 04:05PM
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
(GlobeNewswire) +7.49%
May-10-24 10:11AM
Q1 2024 Eton Pharmaceuticals Inc Earnings Call
(Thomson Reuters StreetEvents)
May-09-24 04:01PM
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
(GlobeNewswire) -7.66%
May-01-24 04:05PM
Eton Pharmaceuticals to Present at the Citizens JMP Life Sciences Conference
(GlobeNewswire) +5.14%
Apr-30-24 11:21AM
Eton Pharmaceuticals Submits New Drug Application to FDA For ET-400
(MT Newswires)
07:00AM
Eton Pharmaceuticals Announces Submission to FDA of New Drug Application for ET-400 (Hydrocortisone Oral Solution)
(GlobeNewswire)
Apr-29-24 04:30PM
Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
(GlobeNewswire)
Mar-22-24 02:20AM
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
(ACCESSWIRE) +9.39%
02:00AM
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE for Phenylketonuria
(GlobeNewswire)
Mar-15-24 03:10PM
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2023 Earnings Call Transcript
(Insider Monkey) -13.68%
09:34AM
Q4 2023 Eton Pharmaceuticals Inc Earnings Call
(Thomson Reuters StreetEvents)
Mar-14-24 08:55PM
ETON Stock Earnings: Eton Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023
(InvestorPlace)
05:35PM
Eton Pharmaceuticals Inc (ETON) Reports Robust Sales Growth and Pipeline Progress in Q4 and ...
(GuruFocus.com)
05:15PM
Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Lags Revenue Estimates
(Zacks)
Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.
PresidentMr. Sean E. Brynjelsen
CFOMr. James R. Gruber CPA
Chief Business OfficerMr. David C. Krempa
Chief Commercial OfficerMs. Ipek Erdogan-Trinkaus
Executive Vice President of OperationsDanka Radosavljevic
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Krempa DavidChief Business OfficerMay 22 '26Option Exercise3.5830,591109,51668,046May 27 06:28 PM
Krempa DavidChief Business OfficerMay 26 '26Option Exercise1.3837,52451,65862,773May 27 06:28 PM
Krempa DavidChief Business OfficerMay 27 '26Option Exercise2.1819,67942,87944,928May 27 06:28 PM
Krempa DavidChief Business OfficerMay 22 '26Sale33.3942,7971,428,81625,249May 27 06:28 PM
Krempa DavidChief Business OfficerMay 26 '26Sale31.4937,5241,181,73225,249May 27 06:28 PM
Krempa DavidChief Business OfficerMay 27 '26Sale31.4719,679619,37525,249May 27 06:28 PM
Krempa DavidOfficerMay 22 '26Proposed Sale35.00100,0003,500,000May 22 04:24 PM
RIEDEL NORBERT GDirectorApr 21 '26Option Exercise8.1032,155260,60567,155Apr 22 04:40 PM
Krempa DavidOfficerJan 14 '26Proposed Sale15.621,94230,334Jan 14 05:17 PM
Gruber James R.OfficerJan 14 '26Proposed Sale15.472,29335,484Jan 14 05:09 PM
BRYNJELSEN SEANOfficerJan 14 '26Proposed Sale15.395,01577,182Jan 14 11:28 AM
Gruber James R.OfficerDec 12 '25Proposed Sale16.885,45091,996Dec 12 05:11 PM
BRYNJELSEN SEANOfficerDec 12 '25Proposed Sale16.888,035135,631Dec 12 05:05 PM
Erdogan-Trinkaus IpekOfficerDec 12 '25Proposed Sale16.91991,674Dec 12 04:50 PM
Krempa DavidOfficerDec 12 '25Proposed Sale16.887,545127,360Dec 12 04:46 PM
Gruber James R.Chief Financial OfficerAug 19 '25Sale16.1639,082631,565205,299Aug 20 05:14 PM
Gruber James R.Chief Financial OfficerAug 20 '25Sale16.022,63142,149204,753Aug 20 05:14 PM
Gruber James R.OfficerAug 18 '25Proposed Sale16.6141,713692,645Aug 19 05:15 PM
Krempa DavidChief Business OfficerJun 12 '25Sale14.9216,977253,297629,669Jun 16 04:56 PM
Krempa DavidChief Business OfficerJun 16 '25Sale14.7310,223150,585612,646Jun 16 04:56 PM
Krempa DavidChief Business OfficerJun 13 '25Sale14.776,800100,436622,869Jun 16 04:56 PM
Opaleye Management Inc.10% OwnerJun 10 '25Buy15.827,930125,4842,770,000Jun 12 04:32 PM
Krempa DavidOfficerJun 12 '25Proposed Sale15.0040,000600,000Jun 12 04:21 PM
BRYNJELSEN SEANPresident & CEOJun 03 '25Sale17.5170,0001,225,9113,013,513Jun 05 05:15 PM
BRYNJELSEN SEANPresident & CEOJun 04 '25Sale17.0070,0001,190,0002,943,513Jun 05 05:15 PM
BRYNJELSEN SEANPresident & CEOJun 05 '25Sale16.8170,0001,176,7002,873,513Jun 05 05:15 PM
BRYNJELSEN SEANOfficerJun 03 '25Proposed Sale18.00210,0003,780,000Jun 03 04:00 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)